Karyopharm Therapeutics Inc.KPTINASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
11.57%
↑ 112% above average
Average (39q)
-98.66%
Historical baseline
Range
High:173.91%
Low:-1538.46%
CAGR
+2.3%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 11.57% |
| Q2 2025 | -55.96% |
| Q1 2025 | 24.52% |
| Q4 2024 | 4.68% |
| Q3 2024 | -271.11% |
| Q2 2024 | 146.39% |
| Q1 2024 | 11.33% |
| Q4 2023 | -21.02% |
| Q3 2023 | -1458.62% |
| Q2 2023 | 93.57% |
| Q1 2023 | -949.02% |
| Q4 2022 | 4.44% |
| Q3 2022 | 27.42% |
| Q2 2022 | -16.98% |
| Q1 2022 | -203.92% |
| Q4 2021 | 173.91% |
| Q3 2021 | 2.82% |
| Q2 2021 | 7.79% |
| Q1 2021 | -30.51% |
| Q4 2020 | 94.60% |
| Q3 2020 | -14.87% |
| Q2 2020 | 19.01% |
| Q1 2020 | -2.82% |
| Q4 2019 | -14.26% |
| Q3 2019 | 6.50% |
| Q2 2019 | 34.46% |
| Q1 2019 | -13.48% |
| Q4 2018 | -20.72% |
| Q3 2018 | -32.27% |
| Q2 2018 | 22.61% |
| Q1 2018 | 3.08% |
| Q4 2017 | -23.08% |
| Q3 2017 | -1.56% |
| Q2 2017 | 9.86% |
| Q1 2017 | -1538.46% |
| Q4 2016 | 5.80% |
| Q3 2016 | 17.86% |
| Q2 2016 | -12.00% |
| Q1 2016 | 7.41% |
| Q4 2015 | 4.71% |